Evidence for a major gene influencing risk of pancreatic cancer
- 1 August 2002
- journal article
- research article
- Published by Wiley in Genetic Epidemiology
- Vol. 23 (2) , 133-149
- https://doi.org/10.1002/gepi.1102
Abstract
Family history of pancreatic cancer, the fifth leading cause of cancer death in the United States, confers a 1.5–13-fold higher risk of developing pancreatic cancer. Pancreatic cancer is associated with several genetic syndromes, including hereditary breast cancer (BRCA2), familial atypical multiple mole melanoma (FAMMM) syndrome, Peutz-Jeghers syndrome, hereditary pancreatitis, and hereditary nonpolyposis colorectal cancer (HNPCC). However, these syndromes explain little of the observed familial aggregation of pancreatic cancer. We performed complex segregation analysis on 287 families ascertained through an index case diagnosed with pancreatic cancer at the Johns Hopkins Medical Institutions between January 1, 1994 and December 31, 1999. We tested for the presence of a major gene controlling either the “age-at-onset of pancreatic cancer” of “susceptibility to pancreatic cancer,” and incorporated smoking data on kindred members as a covariate. We found evidence for involvement of a major gene in the etiology of pancreatic cancer. Whether inheritance was modeled as “age-at-onset” or “susceptibility,” nongenetic transmission models were strongly rejected. However, modeling “age-at-onset” provided a better fit to the observed data than did modeling “susceptibility.” The most parsimonious models included autosomal-dominant inheritance of a rare allele. Under the age-at-onset model, approximately 0.7% of the population appears to be at high risk of developing pancreatic cancer due to this putative gene, whereas 0.4% of the population is at high risk under the susceptibility model. Inclusion of smoking as a covariate did not significantly improve the fit of these models. This hospital-based segregation analysis of pancreatic cancer found evidence supporting the role of a rare major gene influencing risk of pancreatic cancer. Genet. Epidemiol. 23:133–149, 2002 Wiley-Liss, Inc.Keywords
This publication has 30 references indexed in Scilit:
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Relationship of family cancer history to the expression of P53, P21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinomaJournal of Gastrointestinal Cancer, 1997
- Current Management of Pancreatic CarcinomaAnnals of Surgery, 1995
- Pancreatic CarcinomaNew England Journal of Medicine, 1992
- Asymptotic Properties of Maximum Likelihood Estimators and Likelihood Ratio Tests under Nonstandard ConditionsJournal of the American Statistical Association, 1987
- PANCREATIC CANCER IN MOTHER AND DAUGHTERThe Lancet, 1986
- A familial aggregation of pancreatic cancer. An in vitro studyJAMA, 1982
- Ascertainment in the sequential sampling of pedigreesClinical Genetics, 1977
- Familial carcinoma of the pancreas*Clinical Genetics, 1976
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974